Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23003,97,1.08 [0.82-1.44],0.5751864225543938
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23634,180,0.99 [0.80-1.24],0.9586541110249392
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23407,1152,0.97 [0.89-1.06],0.5024100993089107
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23661,414,1.07 [0.93-1.22],0.3406515002200185
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22927,3033,0.97 [0.92-1.03],0.2849399584757355
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23129,2458,1.02 [0.97-1.09],0.4203771374948242
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23416,1165,0.98 [0.90-1.07],0.7099935263515388
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23564,81,1.07 [0.78-1.46],0.6708188623011775
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22093,696,1.03 [0.93-1.15],0.547080331855706
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21340,796,1.03 [0.93-1.15],0.5183388379025042
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21385,219,1.09 [0.90-1.31],0.3854977415206999
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16579,1417,0.97 [0.90-1.05],0.4721694601332999
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21191,315,0.93 [0.77-1.12],0.4306071863614276
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23604,1353,0.99 [0.92-1.08],0.8786701386764306
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23714,467,1.04 [0.91-1.19],0.5559754702729761
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23071,816,0.98 [0.88-1.09],0.659451143751552
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23669,763,1.02 [0.92-1.13],0.7402786667187119
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22431,180,0.99 [0.80-1.24],0.957380374573528
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23772,37,0.82 [0.46-1.46],0.5002658584469826
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23581,675,1.04 [0.93-1.16],0.5187823505602092
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23558,75,1.11 [0.82-1.51],0.4892945600379131
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23687,166,1.07 [0.86-1.32],0.5600436559478952
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23673,152,1.05 [0.84-1.31],0.6797513131023564
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22547,292,1.13 [0.97-1.31],0.1273071655076939
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22479,224,0.87 [0.69-1.09],0.2208333547150871
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22350,99,0.85 [0.60-1.20],0.3464514354393921
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23749,34,0.57 [0.28-1.15],0.1144445172264859
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23705,139,0.90 [0.68-1.18],0.4438510136884572
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23607,41,1.26 [0.88-1.79],0.2057438602693479
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23636,70,0.71 [0.45-1.11],0.1323133559230756
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23536,202,0.87 [0.69-1.10],0.2367426428045548
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23683,58,0.95 [0.63-1.41],0.7888237041430122
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23676,57,0.74 [0.46-1.20],0.2192620243504691
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23518,1046,0.91 [0.82-1.01],0.0633377249666381
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of meninges,23747,73,1.33 [1.04-1.70],0.0226220557818744
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23715,59,0.97 [0.65-1.44],0.8685684790491707
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23741,117,0.99 [0.75-1.31],0.9668415301756124
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm of ovary,23704,147,0.89 [0.68-1.16],0.3809043196490161
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23752,236,0.98 [0.80-1.19],0.8324846501287941
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23758,216,0.88 [0.70-1.10],0.2724553248176551
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23690,56,0.89 [0.57-1.38],0.5987936041737365
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23756,133,0.87 [0.65-1.17],0.3617792708386057
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23718,244,0.88 [0.71-1.09],0.2335518412673131
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23677,440,1.00 [0.87-1.15],0.9730478114483284
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23757,249,0.94 [0.77-1.14],0.5276204750120987
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Carcinoma in situ of breast,19223,122,1.00 [0.77-1.30],0.99274453639993
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19295,142,0.99 [0.78-1.27],0.9639190940427892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19289,30,0.98 [0.56-1.70],0.9347260410579374
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19316,57,0.53 [0.30-0.93],0.0281880842538103
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23709,126,1.24 [1.01-1.52],0.0427583564671697
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Haemangioma, any site",23710,124,1.20 [0.97-1.48],0.0989105284101325
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Leiomyoma of uterus,22914,498,0.98 [0.86-1.12],0.7835933974481772
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Lung cancer and mesothelioma,17050,280,0.98 [0.81-1.19],0.875327073676337
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Lymphoid leukaemia,19293,34,0.95 [0.55-1.62],0.8369130481485059
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19415,156,1.10 [0.89-1.36],0.3945907084719221
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19353,94,1.15 [0.88-1.49],0.2959818219851527
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19422,163,1.11 [0.90-1.37],0.3381713677827873
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19320,61,1.12 [0.80-1.58],0.5075451265073417
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19321,62,1.00 [0.68-1.46],0.9902382388973008
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19306,47,1.05 [0.69-1.58],0.8234027375382125
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19389,130,1.31 [1.09-1.58],0.004152545401027
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19351,92,0.93 [0.67-1.30],0.6854933981551576
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19329,70,1.01 [0.72-1.44],0.9339737511222884
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19295,36,1.23 [0.83-1.81],0.3031787247466679
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19329,70,0.85 [0.57-1.28],0.4452169026912674
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Melanocytic naevi,23539,203,1.15 [0.97-1.37],0.1136667640404082
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23733,68,0.53 [0.32-0.87],0.0130207181689791
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Melanoma in situ,19287,76,0.87 [0.59-1.27],0.4675102593570399
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19330,71,0.54 [0.32-0.89],0.016048820247687
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19390,131,0.95 [0.72-1.24],0.6964386166705028
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19465,206,0.98 [0.79-1.21],0.8179577517004375
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19340,81,1.01 [0.73-1.40],0.9621656376742996
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,Other benign neoplasms of skin,23575,154,1.05 [0.84-1.31],0.6984884690847142
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20055,796,1.00 [0.90-1.12],0.9279355015039502
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20091,832,1.00 [0.90-1.11],0.9621023397252874
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23488,340,1.06 [0.91-1.23],0.4720492694899166
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22042,85,0.93 [0.66-1.32],0.7020629547488209
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23220,72,1.09 [0.79-1.50],0.6027323596735092
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22892,2572,1.02 [0.97-1.08],0.4548628874950028
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22366,27,0.65 [0.30-1.40],0.2687322131501005
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23422,46,0.84 [0.51-1.40],0.5086506417275414
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23264,1307,1.07 [0.99-1.16],0.0901589046176847
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23264,1307,1.07 [0.99-1.16],0.0901589046176847
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22025,68,0.82 [0.53-1.25],0.3441501308290892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23412,1073,1.09 [1.00-1.18],0.043741149135885
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23478,102,0.89 [0.64-1.23],0.4765803484666085
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23195,47,0.85 [0.51-1.40],0.5242936792360268
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23202,54,1.24 [0.90-1.71],0.1948622964612251
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23585,209,0.86 [0.69-1.09],0.2129669788583026
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23680,53,1.20 [0.87-1.66],0.2683454472146754
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23553,177,0.80 [0.61-1.04],0.0965267313080356
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22454,115,1.10 [0.86-1.42],0.4430002432234449
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19173,209,1.22 [1.02-1.44],0.0249738955284341
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22530,61,0.86 [0.56-1.31],0.4779681635847577
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22526,57,0.89 [0.58-1.37],0.607845108141244
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19008,44,1.31 [0.95-1.82],0.1043891314833978
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21788,54,0.95 [0.63-1.45],0.8173477134346744
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21523,205,1.08 [0.89-1.31],0.4192383440292444
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23394,420,1.05 [0.91-1.21],0.4795563275960319
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23234,260,0.83 [0.67-1.03],0.0935715375260369
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23032,58,1.14 [0.81-1.60],0.453122459363838
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23436,1702,0.99 [0.92-1.06],0.7945005254680781
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21068,1664,0.98 [0.91-1.05],0.5512320536338258
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19007,43,1.08 [0.70-1.65],0.7308425136573766
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21139,102,0.99 [0.73-1.33],0.9243851339625964
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19210,246,1.09 [0.91-1.30],0.3559030252591776
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19004,40,0.90 [0.54-1.51],0.6914667616117973
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21665,2701,1.02 [0.96-1.08],0.4950802308652021
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19147,183,1.10 [0.89-1.35],0.3705913102461287
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19435,471,1.08 [0.95-1.22],0.2699897390075584
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23687,309,1.08 [0.93-1.26],0.3276596900445166
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23523,145,1.06 [0.84-1.34],0.61173354167561
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19052,88,1.10 [0.82-1.47],0.5355782841484784
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19014,50,1.26 [0.92-1.74],0.1555824065198701
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23017,1980,1.01 [0.95-1.08],0.7794125616927999
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19141,177,0.90 [0.70-1.16],0.4299467795463789
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19135,171,1.26 [1.05-1.52],0.0122968596025758
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19422,458,1.06 [0.93-1.21],0.4066116279496629
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19034,70,1.20 [0.89-1.61],0.2254893675950844
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23517,139,0.97 [0.75-1.26],0.8412653936935284
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19498,534,1.10 [0.98-1.24],0.1080843239505743
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19442,478,1.09 [0.97-1.24],0.157076205863999
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21380,62,1.06 [0.74-1.51],0.7411732703736252
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23007,4043,1.03 [0.99-1.08],0.1508890646829803
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21100,63,0.90 [0.60-1.35],0.6213062988964902
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21114,77,0.81 [0.55-1.20],0.2903902996065808
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23606,1764,1.04 [0.97-1.12],0.2918595721809575
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23610,1763,1.04 [0.97-1.12],0.2935708004871001
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21110,73,0.87 [0.58-1.28],0.4714579365251408
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23411,1369,1.02 [0.95-1.11],0.5480054526043195
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20260,1296,1.11 [1.03-1.20],0.006195200212312
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23762,156,1.02 [0.80-1.29],0.9027120725247196
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23016,42,0.84 [0.49-1.44],0.5283530938543709
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22161,119,0.82 [0.60-1.13],0.2269052889775824
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22211,169,1.02 [0.81-1.28],0.8652629305397216
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19180,216,1.10 [0.91-1.32],0.3180578470915904
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22189,122,1.18 [0.93-1.49],0.178752975010101
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1483,38,0.79 [0.44-1.40],0.4119955302182205
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1574,146,1.00 [0.79-1.27],0.9883820866455556
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22092,25,1.24 [0.74-2.08],0.4085497655674968
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1468,24,1.10 [0.66-1.83],0.7236394837583042
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23365,1298,1.06 [0.98-1.15],0.160107558684786
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23264,290,0.98 [0.82-1.18],0.8634508769572716
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21736,418,1.00 [0.86-1.15],0.9588072417008656
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19579,615,0.97 [0.85-1.10],0.5885282272694069
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23685,206,0.74 [0.57-0.96],0.024303980280228
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22878,42,0.60 [0.31-1.13],0.1154005596453426
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22446,751,0.95 [0.84-1.06],0.3437758758334887
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22914,78,0.79 [0.52-1.19],0.2644638200023279
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22866,30,0.60 [0.28-1.27],0.1834895603245176
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22975,139,0.98 [0.75-1.27],0.8544729629655247
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15441,1264,1.01 [0.93-1.10],0.8189791278617792
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,AV-block,20838,214,0.96 [0.77-1.19],0.697452961156616
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23730,268,0.92 [0.76-1.12],0.4159235842603732
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14284,107,1.11 [0.84-1.45],0.4683061373842643
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20742,118,1.12 [0.87-1.43],0.3772476804301725
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20695,71,1.12 [0.82-1.53],0.459738986035647
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23768,27,1.02 [0.58-1.79],0.9548570674840914
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Conduction disorders,21257,633,1.01 [0.90-1.14],0.8447085913076755
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22980,1296,0.95 [0.88-1.04],0.2993738966198309
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21399,6314,1.00 [0.96-1.04],0.9335403830138572
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22480,218,0.76 [0.59-0.97],0.0299470348985133
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Endocarditis,20671,47,0.92 [0.58-1.46],0.7140323394997685
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23684,724,1.09 [0.99-1.21],0.0877594946186123
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Hypertension,21942,5309,1.01 [0.97-1.05],0.7156523361730251
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21951,5318,1.01 [0.97-1.05],0.7352696150209335
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23668,34,1.15 [0.74-1.81],0.5296066991928625
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16783,150,1.16 [0.94-1.44],0.164883615846005
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16700,67,1.46 [1.13-1.89],0.0043842998603945
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Hypotension,23656,928,1.04 [0.94-1.14],0.4434127721155535
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23116,84,0.66 [0.43-1.01],0.0571318948990942
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23159,1464,0.94 [0.86-1.02],0.1189678324430621
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23501,397,1.00 [0.86-1.16],0.9845306735668636
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20891,267,1.13 [0.96-1.33],0.13969828487709
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23583,521,1.02 [0.89-1.16],0.7916071158725073
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22114,419,1.04 [0.91-1.20],0.5518280641147555
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23747,77,0.90 [0.62-1.31],0.5842485311791277
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23764,206,1.06 [0.87-1.29],0.5554580886035922
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22294,32,0.71 [0.37-1.39],0.3234049839548827
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22886,50,0.83 [0.50-1.35],0.4466047776083548
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20942,318,1.06 [0.90-1.24],0.5093169548542751
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22897,61,1.01 [0.69-1.49],0.94823896138899
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23008,172,1.13 [0.93-1.38],0.2096664970917142
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20771,147,0.77 [0.57-1.03],0.0818414981590133
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22335,73,0.97 [0.67-1.39],0.8531896917334321
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22303,41,1.03 [0.67-1.60],0.8831368604685709
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22689,30,1.19 [0.76-1.87],0.4452790282143986
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22396,134,1.00 [0.77-1.31],0.9702793229778512
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21303,679,1.07 [0.96-1.20],0.1938627796899822
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22764,36,0.78 [0.43-1.43],0.4210082234017143
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23283,447,1.04 [0.91-1.19],0.5662688459251248
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23263,284,1.16 [0.99-1.36],0.0603603050887073
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23124,465,1.02 [0.89-1.17],0.8191650633975796
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14428,251,1.19 [1.02-1.40],0.0313553080572329
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23071,246,1.00 [0.82-1.21],0.983066685424386
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22544,282,0.75 [0.61-0.94],0.0120593541919072
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23365,386,1.12 [0.97-1.28],0.1151114530317473
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23699,502,1.12 [0.99-1.26],0.0668722228218987
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20809,185,0.89 [0.70-1.14],0.3484192743318147
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23256,277,1.18 [1.01-1.37],0.0411723964687014
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22793,134,0.73 [0.52-1.01],0.0558133309339757
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23492,460,0.97 [0.84-1.12],0.7090420185731572
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23468,500,0.99 [0.87-1.13],0.8888878450867796
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23085,62,0.98 [0.67-1.43],0.9135937525701032
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22872,36,0.95 [0.56-1.61],0.8503901595743627
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23286,182,1.00 [0.80-1.25],0.9834521487697117
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23234,172,0.88 [0.68-1.14],0.3218609918807565
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Varicose veins,22642,380,0.97 [0.83-1.13],0.6746789922329807
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22846,84,1.13 [0.85-1.50],0.4088497755351611
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23587,606,0.99 [0.88-1.12],0.9168169383349604
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23734,198,1.00 [0.81-1.24],0.985494359925831
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21111,1598,1.02 [0.95-1.10],0.5535100804849036
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,Any mental disorder,23248,3735,0.98 [0.93-1.03],0.3444294622686278
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23709,235,1.00 [0.83-1.22],0.9753833521071692
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21231,1718,0.98 [0.91-1.05],0.5284302235378128
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19590,77,0.96 [0.68-1.36],0.8179877284738859
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,Smoking dependency,23420,1037,0.98 [0.89-1.07],0.6320418327771004
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20717,1204,0.96 [0.88-1.05],0.383573518062398
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter V Mental and behavioural disorders,Vascular dementia,23349,90,0.94 [0.66-1.32],0.701552786948825
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23770,322,0.85 [0.70-1.03],0.0987183227506397
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16263,51,0.89 [0.57-1.40],0.6135938269209149
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Bell's palsy,21911,70,1.06 [0.76-1.48],0.7250691526229017
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22392,551,0.93 [0.81-1.06],0.2657674336914234
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23419,186,0.91 [0.72-1.15],0.4247446076017838
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23705,235,0.83 [0.66-1.05],0.1181720955596089
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23346,37,0.98 [0.59-1.62],0.9316195563155608
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23760,44,1.15 [0.79-1.69],0.45987512179489
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23275,42,0.89 [0.54-1.47],0.646815752768525
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Epilepsy,22516,246,1.00 [0.83-1.21],0.983442662500689
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23410,1140,0.92 [0.84-1.01],0.0985819768494335
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23728,308,1.02 [0.86-1.20],0.8605084123348035
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23234,2507,1.01 [0.95-1.07],0.7974990705445199
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23454,41,1.17 [0.80-1.71],0.4085316559560553
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Hemiplegia,23657,187,0.77 [0.59-1.01],0.0555639371389774
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23288,55,0.85 [0.54-1.35],0.4886207390278377
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23754,65,0.78 [0.50-1.21],0.2682554295865512
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21954,113,1.11 [0.87-1.42],0.403724437807559
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21896,55,1.06 [0.73-1.54],0.7558602245488182
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Memory loss,23240,93,1.01 [0.75-1.38],0.926321098821307
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Migraine,22708,438,0.90 [0.77-1.05],0.1659972784463232
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23672,397,0.88 [0.75-1.04],0.1408875374669845
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Motor neuron disease,16350,113,0.91 [0.67-1.23],0.5340424663964494
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23572,126,1.07 [0.85-1.36],0.5573812301481544
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23047,1206,0.99 [0.91-1.07],0.7588907617178564
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Neurological diseases,22369,3210,0.96 [0.91-1.01],0.1245889708974231
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23436,127,0.91 [0.68-1.22],0.5318363874559264
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22208,367,0.93 [0.79-1.10],0.4119476000720657
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23717,196,0.82 [0.64-1.05],0.1158277848136675
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19219,578,0.93 [0.82-1.06],0.282363454414556
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23291,58,1.25 [0.93-1.68],0.1400331167140072
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23344,111,0.77 [0.54-1.08],0.1298828801311397
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23564,144,1.04 [0.82-1.32],0.7443492145393508
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21919,78,1.03 [0.75-1.43],0.8410172334517004
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22336,66,1.01 [0.71-1.43],0.9774123834653532
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23668,435,1.00 [0.86-1.15],0.946372197794062
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22612,342,0.79 [0.65-0.96],0.0157820914036631
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23748,144,0.96 [0.74-1.25],0.7811663673133817
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23306,73,1.02 [0.72-1.43],0.927681660152233
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23769,78,0.93 [0.65-1.34],0.7046929844331811
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23619,276,0.75 [0.60-0.93],0.0107609816114306
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23555,34,1.09 [0.69-1.73],0.7090024970316524
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23760,138,0.95 [0.73-1.24],0.7109859653468833
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21902,61,1.05 [0.73-1.51],0.7829644504351065
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23770,325,0.85 [0.70-1.03],0.0901202596541552
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23309,87,0.90 [0.63-1.29],0.5591034532505399
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23255,93,0.79 [0.55-1.15],0.2220855538300193
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23370,424,0.96 [0.83-1.12],0.6021776631474857
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23643,138,0.96 [0.73-1.26],0.7591378039719322
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22805,51,1.33 [0.99-1.78],0.0545787815055348
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22802,48,1.20 [0.85-1.69],0.2978238236764575
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23663,57,0.79 [0.49-1.27],0.3281665859550992
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23520,147,0.92 [0.71-1.21],0.5614142286356971
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1475,30,1.01 [0.61-1.67],0.9709026997118152
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1761,56,0.88 [0.57-1.38],0.5822132744957724
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23244,82,1.03 [0.75-1.42],0.8549013341127716
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23619,910,0.95 [0.86-1.05],0.3355928997524753
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23402,648,1.16 [1.05-1.28],0.0031532305017459
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23014,260,1.18 [1.01-1.37],0.0350775894478896
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23693,747,0.89 [0.79-1.00],0.0579598285630013
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23758,61,1.13 [0.81-1.58],0.4693030088457716
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23625,679,0.89 [0.79-1.01],0.0729819382203936
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23732,359,0.99 [0.85-1.16],0.9129584931301182
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23685,184,1.06 [0.86-1.30],0.5982967328267074
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22792,38,1.35 [0.96-1.90],0.0866362926917803
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22796,42,1.44 [1.08-1.92],0.0125159178224556
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22815,61,0.87 [0.57-1.33],0.5296648258420741
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23691,619,0.96 [0.85-1.09],0.5430068881717424
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23221,149,1.01 [0.79-1.29],0.9313701472882394
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23003,57,0.57 [0.33-0.98],0.0437540104607151
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23463,90,0.82 [0.57-1.19],0.3011088240959394
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23651,278,1.03 [0.87-1.23],0.7172073961743449
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23126,180,0.82 [0.64-1.07],0.1387290421626001
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23620,119,0.93 [0.70-1.24],0.6104076068342534
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23475,403,0.97 [0.83-1.13],0.6856560167892213
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23300,138,0.95 [0.73-1.24],0.7267660597009675
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22204,2210,1.04 [0.97-1.10],0.2784704308287773
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23618,245,1.01 [0.84-1.22],0.9096948160101964
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23748,144,1.20 [0.98-1.47],0.0755366467593952
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23086,332,1.18 [1.03-1.35],0.0159281833035308
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23431,58,0.68 [0.40-1.14],0.1437373640700165
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23746,49,1.03 [0.68-1.57],0.8827893072260325
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22837,83,1.11 [0.82-1.49],0.5026671595050036
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22881,127,1.11 [0.88-1.41],0.3813080485701207
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22802,93,0.95 [0.69-1.31],0.7660983569146532
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23003,57,0.81 [0.52-1.29],0.3801046941847374
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22765,56,1.03 [0.71-1.51],0.8643133921429399
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23176,104,1.05 [0.79-1.38],0.7409450962453656
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23230,158,1.04 [0.83-1.30],0.7359976967850057
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22865,111,1.28 [1.04-1.58],0.0186683486822591
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22791,82,1.19 [0.92-1.54],0.1898292337082248
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22767,58,0.89 [0.58-1.37],0.5979707896988703
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21817,1823,0.99 [0.92-1.06],0.7730829724272243
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22829,75,1.06 [0.77-1.46],0.733435687629475
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23541,379,1.02 [0.88-1.19],0.7489968137724228
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23202,40,1.38 [1.03-1.85],0.0305467103904483
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23310,148,1.01 [0.79-1.29],0.9511765727844894
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23546,101,1.00 [0.75-1.34],0.9793165417464668
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23731,94,1.24 [0.98-1.56],0.0787552782698639
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23666,124,1.09 [0.86-1.39],0.4742877144429999
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23509,64,1.18 [0.87-1.60],0.2815440963024666
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23511,66,1.12 [0.82-1.55],0.4740161258072954
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23677,702,1.06 [0.95-1.18],0.2875090234645104
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23456,481,1.11 [0.98-1.26],0.0908919366908307
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23078,103,0.80 [0.56-1.14],0.223233676491913
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23048,73,0.98 [0.69-1.40],0.9240987411968364
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23530,74,1.06 [0.76-1.46],0.7439259248657698
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23664,208,0.95 [0.77-1.17],0.6282793680627251
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23512,56,1.08 [0.76-1.54],0.674341498995237
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,All influenza,22287,113,1.11 [0.86-1.43],0.4146201284430025
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22286,112,1.12 [0.87-1.44],0.3980712261111699
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16887,117,0.98 [0.74-1.29],0.8661109946333773
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23648,251,0.92 [0.76-1.12],0.4252053936796944
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18433,1822,1.05 [0.98-1.12],0.153123017180331
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18568,1798,1.05 [0.98-1.12],0.1387362057914125
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23408,113,1.16 [0.92-1.47],0.214034806218211
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22234,60,1.27 [0.96-1.68],0.0951895482638127
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20525,345,1.03 [0.88-1.20],0.7394394992138797
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20241,61,1.07 [0.74-1.53],0.7236838360796386
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22772,2592,1.02 [0.96-1.08],0.5360867480739494
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22661,59,0.48 [0.28-0.84],0.0099681571554894
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22727,125,0.90 [0.68-1.20],0.4789339696928421
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23620,897,0.95 [0.85-1.05],0.3186412523373847
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22666,64,0.76 [0.48-1.19],0.224452084116829
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21950,4473,1.02 [0.98-1.07],0.3330599093941032
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22893,291,0.95 [0.80-1.14],0.5993579380414984
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Early onset COPD,23001,278,0.94 [0.78-1.13],0.5278847760569401
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Emphysema,20410,230,1.06 [0.89-1.28],0.51402848513259
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22309,202,0.84 [0.66-1.08],0.1687142223922703
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23596,1422,0.99 [0.91-1.07],0.8038084712653721
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22344,237,0.88 [0.70-1.09],0.2367043269405921
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Later onset COPD,22967,619,0.95 [0.84-1.08],0.421675817289167
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23763,190,0.85 [0.66-1.09],0.1914278532579651
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Nasal polyp,22662,60,0.86 [0.56-1.32],0.4830727581639883
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23572,803,0.99 [0.89-1.10],0.8591733423259066
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23604,1519,1.06 [0.99-1.14],0.0896363821352186
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23286,684,0.96 [0.86-1.08],0.4953797830808314
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other pleural conditions,22120,35,0.91 [0.53-1.57],0.7423364228082874
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23695,299,0.93 [0.77-1.12],0.4176070438423982
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23690,1031,1.06 [0.97-1.16],0.197993099984736
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pleural effusion,22808,723,1.09 [0.98-1.21],0.1010748559066317
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pleural plaque,22128,43,1.06 [0.68-1.64],0.8050392052489558
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23386,1212,1.00 [0.92-1.09],0.9183089688896412
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23737,164,0.85 [0.65-1.12],0.2473078222904687
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pneumothorax,22174,89,0.88 [0.61-1.25],0.4702361714339036
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pollen allergy,23746,211,0.92 [0.74-1.15],0.4683969259458921
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23450,54,1.13 [0.78-1.62],0.5185803384169083
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16812,42,0.88 [0.52-1.49],0.6339559515392954
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23553,784,0.99 [0.89-1.10],0.8435362926864705
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22853,251,0.92 [0.76-1.12],0.425604266313922
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22356,182,0.99 [0.79-1.24],0.9458649743973186
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23416,144,0.86 [0.65-1.15],0.3059563339282232
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11433,89,0.90 [0.64-1.28],0.5694644703691802
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16982,35,0.93 [0.55-1.57],0.7776161428148967
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23600,120,0.79 [0.58-1.09],0.1517585903693512
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute gastritis,17834,71,1.18 [0.88-1.57],0.2748913311842915
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21789,144,0.84 [0.63-1.11],0.2244448386877887
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23267,75,1.21 [0.92-1.59],0.168909804598989
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23019,31,0.81 [0.43-1.54],0.522727960565349
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18063,300,1.02 [0.86-1.21],0.7835307680948165
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21715,70,1.20 [0.90-1.61],0.2131698451265443
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23399,70,1.21 [0.90-1.62],0.2017472522058049
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Cholecystitis,21797,152,0.90 [0.69-1.17],0.4138896665508427
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22684,1039,1.01 [0.92-1.10],0.8862677465690831
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Chronic gastritis,18057,294,1.18 [1.02-1.36],0.0254724915147967
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21681,36,0.49 [0.24-0.98],0.0441099629205749
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23698,64,1.15 [0.83-1.60],0.3939152489845156
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Coeliac disease,22443,123,1.26 [1.03-1.55],0.0241855213661775
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22123,90,0.70 [0.47-1.04],0.0762173738609013
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23649,141,1.09 [0.87-1.36],0.4688135149523548
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Constipation,23476,1475,1.03 [0.96-1.11],0.4294502916143431
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Crohn disease,22108,75,0.88 [0.60-1.28],0.4983427767280485
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23453,53,0.80 [0.50-1.31],0.3803260127228821
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22110,77,0.96 [0.68-1.36],0.8114105137951892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Dental caries,23049,203,0.87 [0.70-1.10],0.2519709284086996
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22348,2119,1.01 [0.95-1.08],0.6924722829039149
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23639,159,0.78 [0.60-1.03],0.0857768891440841
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of liver,23683,695,1.01 [0.90-1.13],0.8525674495195861
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21771,4008,1.01 [0.96-1.05],0.8065489356283617
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23364,518,1.10 [0.98-1.23],0.1070231497708047
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23660,468,1.07 [0.94-1.22],0.304608659354303
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22952,106,1.10 [0.85-1.42],0.4706813789569469
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22817,57,0.62 [0.36-1.04],0.0717028496867876
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23520,1200,1.10 [1.02-1.19],0.0140025662279482
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22822,93,1.08 [0.82-1.43],0.5639458111641013
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23034,1389,0.98 [0.90-1.06],0.6425679105518521
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19726,2779,0.96 [0.90-1.02],0.1457813906980316
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17880,117,1.10 [0.85-1.41],0.4751666314324392
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23721,97,1.15 [0.88-1.49],0.2967452447752092
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23686,55,1.17 [0.85-1.60],0.3335522574355324
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23070,82,1.13 [0.84-1.51],0.426355217510594
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17050,103,0.96 [0.71-1.28],0.7640381128409354
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18346,583,0.99 [0.87-1.12],0.834731798053892
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastric ulcer,18068,305,0.86 [0.71-1.05],0.1341818090384743
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20184,2421,1.00 [0.94-1.06],0.8807859417068773
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18183,420,0.95 [0.82-1.11],0.5170440716348785
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18590,7292,1.00 [0.96-1.03],0.8827890915496717
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,GI-bleeding,23282,962,1.08 [0.99-1.18],0.1014723652385835
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22908,62,1.05 [0.73-1.50],0.795439698387483
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17790,1089,0.94 [0.85-1.03],0.1807485474215365
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23020,32,1.42 [1.01-2.00],0.042790330782339
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Hernia,22731,2502,1.04 [0.98-1.10],0.1928233381034374
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Impacted teeth,23694,50,1.25 [0.93-1.69],0.1414515357356212
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Impaction of intestines,17008,61,1.12 [0.80-1.56],0.5250726807352996
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20375,146,1.32 [1.11-1.57],0.0019254659763135
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17031,84,0.97 [0.70-1.35],0.8726947360882834
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22468,148,1.20 [0.98-1.46],0.0745690781936983
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17646,699,0.92 [0.82-1.04],0.1811243195483965
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23760,300,1.10 [0.94-1.29],0.2242269317015397
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22740,707,1.01 [0.90-1.12],0.9057486510716742
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22981,948,1.01 [0.92-1.11],0.8540959640406682
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17895,132,0.93 [0.71-1.23],0.6120390345324231
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Oesophagitis,18265,502,0.89 [0.77-1.03],0.1140315876240762
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23729,139,0.90 [0.68-1.18],0.4275455991891211
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20283,54,1.29 [0.95-1.75],0.1035893376796138
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18033,1086,0.96 [0.87-1.05],0.3788287890542459
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21899,254,1.09 [0.92-1.29],0.3208631906424082
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21812,167,0.95 [0.74-1.20],0.6491045902574042
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18317,1370,0.96 [0.88-1.04],0.3001436139073991
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21887,4940,0.97 [0.93-1.02],0.2256773917462559
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22822,201,1.15 [0.96-1.37],0.118153446570092
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23566,578,1.03 [0.91-1.16],0.6078002788693566
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18277,514,1.04 [0.92-1.18],0.5059892603287075
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21783,138,0.76 [0.56-1.04],0.0877425948552438
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23602,410,1.05 [0.91-1.21],0.510906188438399
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18693,930,0.99 [0.89-1.09],0.7913639870887448
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23298,978,1.08 [0.99-1.18],0.0890018347198388
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23002,156,1.13 [0.92-1.39],0.2427736101495524
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18472,1525,1.02 [0.95-1.10],0.6174765172427987
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19596,1833,0.99 [0.93-1.06],0.8267690552388767
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23077,89,1.10 [0.82-1.46],0.5224929077387842
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22867,834,1.01 [0.91-1.11],0.9052556665105478
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17238,291,0.99 [0.83-1.18],0.9414247107113886
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23676,64,1.18 [0.89-1.58],0.250878515651548
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17378,431,1.06 [0.92-1.21],0.4279258802900891
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22441,121,1.20 [0.96-1.50],0.1082557321266647
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23762,64,1.27 [0.96-1.68],0.0883287100912725
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22848,116,1.05 [0.81-1.35],0.7350339430811513
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Toxic colitis,22088,55,1.14 [0.80-1.63],0.4739273470485324
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17973,210,1.08 [0.89-1.31],0.4294307338495617
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22182,149,0.95 [0.74-1.22],0.6717709197641407
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22159,126,0.88 [0.65-1.17],0.3744251745935799
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20381,152,0.91 [0.70-1.18],0.4748983711239807
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17115,168,1.12 [0.92-1.38],0.2542946326256455
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Ventral hernia,20449,220,1.26 [1.08-1.47],0.0031541631680556
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XI Diseases of the digestive system,Volvulus,17020,73,1.06 [0.77-1.46],0.7139704774227987
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23694,216,0.77 [0.60-0.99],0.0392003882523416
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23493,76,0.68 [0.44-1.06],0.0863312796779958
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21990,195,0.94 [0.75-1.17],0.5782724330754659
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23295,547,0.93 [0.81-1.07],0.3362259632610897
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22878,130,1.32 [1.10-1.58],0.0028853263513597
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22076,281,0.94 [0.78-1.14],0.5414971156938837
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23496,238,1.23 [1.06-1.43],0.006780511470304
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23671,413,1.14 [1.00-1.29],0.0487550888491037
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23302,44,0.98 [0.62-1.55],0.9428767595614408
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22381,2746,0.97 [0.92-1.03],0.3890436599210608
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23376,407,0.96 [0.83-1.12],0.602106674944056
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23246,277,0.95 [0.80-1.14],0.6141078542159906
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23486,738,1.02 [0.91-1.14],0.7281079417418888
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23752,66,0.64 [0.40-1.04],0.0717345831631809
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21882,87,0.93 [0.66-1.30],0.6621168197828387
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23010,41,1.18 [0.81-1.74],0.3896895607648232
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23482,224,1.22 [1.04-1.43],0.0123663510600897
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22157,362,1.01 [0.86-1.17],0.9416753420286352
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21842,47,0.70 [0.40-1.21],0.2040878612315312
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23681,70,1.00 [0.70-1.43],0.9830323254574732
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22881,133,1.09 [0.85-1.38],0.4993707941982769
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23564,147,1.12 [0.90-1.39],0.3179015795099673
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23300,42,1.06 [0.67-1.68],0.7994767362005855
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21851,56,1.00 [0.67-1.48],0.9955938474060576
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23186,1391,0.99 [0.91-1.07],0.7273789546852009
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22187,392,1.02 [0.88-1.18],0.7843671861221059
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21846,51,0.81 [0.50-1.32],0.3975790141364537
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23695,278,0.92 [0.76-1.11],0.4008239815965186
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23332,74,1.19 [0.89-1.58],0.2353616714765296
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23632,215,0.97 [0.79-1.19],0.7688281096847929
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23722,244,0.80 [0.64-1.01],0.0560775477732799
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21936,141,0.92 [0.71-1.20],0.5510178568580948
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22022,227,1.06 [0.88-1.27],0.5456030420246791
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23710,232,0.79 [0.62-1.00],0.0466491879585462
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21972,177,0.93 [0.72-1.19],0.5392736195857761
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23739,128,0.88 [0.66-1.18],0.4061479670937225
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20276,115,1.12 [0.88-1.42],0.3644219201002979
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21595,5543,1.02 [0.98-1.06],0.2581235457317444
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20389,4337,1.03 [0.98-1.07],0.2388413395832042
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20228,67,0.86 [0.57-1.28],0.4526778391628641
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20385,134,0.80 [0.59-1.08],0.1468113796129173
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20434,183,1.02 [0.83-1.26],0.8260278959585805
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23522,102,1.00 [0.75-1.33],0.9838355056262884
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20356,105,0.89 [0.64-1.22],0.4571872162015173
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17256,1204,1.06 [0.97-1.14],0.1827596641797269
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23628,200,0.77 [0.60-1.00],0.0518093444064581
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20757,506,0.90 [0.78-1.04],0.1366057105185727
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19969,7068,1.01 [0.97-1.04],0.6601969127232232
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21275,116,0.94 [0.70-1.25],0.6514760366175789
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20282,121,0.82 [0.59-1.12],0.2074547025985595
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20763,602,1.00 [0.89-1.12],0.9844285398820206
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22872,2621,0.98 [0.92-1.04],0.4811279667373677
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20319,158,1.02 [0.81-1.28],0.8743568482596383
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20500,339,1.00 [0.85-1.17],0.9979854205141796
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20316,155,0.95 [0.74-1.21],0.6717689313651367
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22905,93,0.90 [0.64-1.27],0.5535443694966233
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17682,1630,0.99 [0.92-1.07],0.8898326698590833
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16232,180,1.15 [0.94-1.40],0.1653394476985864
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23758,177,1.12 [0.91-1.38],0.2750187926598154
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16144,92,1.13 [0.87-1.47],0.3752469742903764
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16558,506,1.12 [1.00-1.25],0.0548167043416266
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20453,292,1.01 [0.85-1.20],0.9080136451347984
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16600,548,0.88 [0.77-1.01],0.0725075530348696
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20309,58,0.77 [0.48-1.25],0.2902012770722887
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20872,621,0.98 [0.87-1.10],0.7086784814876812
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20542,291,0.94 [0.78-1.13],0.5057859028364025
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16560,508,0.88 [0.76-1.02],0.0843405693017287
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20236,75,0.85 [0.58-1.25],0.4111767268457542
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20219,58,0.83 [0.53-1.30],0.4144506934305415
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21204,45,1.09 [0.72-1.65],0.6810113024132671
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23357,2198,0.99 [0.93-1.06],0.8344953851438146
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22744,1585,0.96 [0.89-1.04],0.2914486380227735
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23594,521,1.03 [0.90-1.16],0.7000887631299323
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18709,2657,1.03 [0.97-1.09],0.3690992466927774
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16112,60,0.88 [0.58-1.34],0.54550636621413
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20250,89,1.24 [0.97-1.58],0.0870866587854761
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16093,41,0.98 [0.61-1.57],0.9390559070776416
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16233,181,1.07 [0.88-1.31],0.4847531713835072
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21419,260,1.02 [0.85-1.22],0.8583437871000077
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21656,497,1.08 [0.96-1.22],0.1957243169634826
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23746,96,1.14 [0.88-1.49],0.3137966737459415
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22022,1771,0.97 [0.90-1.04],0.3929919086604971
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20274,113,1.05 [0.82-1.36],0.6899902895430359
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16258,206,1.02 [0.83-1.24],0.8745013924955385
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20956,705,0.98 [0.87-1.09],0.6826094930342481
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18271,2219,1.03 [0.97-1.09],0.322839461669162
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22925,113,1.08 [0.83-1.39],0.57278211125464
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23752,75,0.68 [0.44-1.06],0.0907568223840251
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20227,66,1.29 [0.99-1.68],0.060277103059634
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21441,1280,1.00 [0.92-1.09],0.947422719601304
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20234,73,0.84 [0.56-1.25],0.3808834933261682
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17784,1732,1.02 [0.95-1.09],0.6523921223779945
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21286,127,1.10 [0.87-1.39],0.4206542541322495
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20210,49,0.90 [0.57-1.41],0.6405143112147773
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20424,173,1.11 [0.91-1.36],0.3098061026375865
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20659,498,1.02 [0.89-1.16],0.7960433365520235
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23264,452,0.94 [0.81-1.09],0.4199647588488643
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20811,560,0.89 [0.78-1.02],0.101596691314495
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23606,503,1.02 [0.90-1.16],0.7620648564343921
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23745,56,0.99 [0.67-1.48],0.9708505851058642
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20357,196,1.14 [0.95-1.36],0.1683657599778197
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18212,791,1.01 [0.91-1.12],0.9147850242975626
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20737,576,1.02 [0.90-1.15],0.7652626311493569
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20269,108,1.11 [0.86-1.43],0.4111713818223281
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16124,72,1.25 [0.95-1.64],0.107386099414337
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18355,2303,1.03 [0.97-1.09],0.3896968367476103
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16780,728,1.06 [0.95-1.18],0.2890096237905526
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23068,256,0.80 [0.64-1.01],0.0568425593267873
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23720,70,1.24 [0.94-1.64],0.132036893209532
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21783,48,0.89 [0.55-1.45],0.6375263190094116
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16128,76,0.69 [0.44-1.06],0.090451160966345
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20348,97,0.91 [0.65-1.26],0.556861246418374
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16576,524,1.04 [0.92-1.18],0.5465919327306565
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20443,282,0.98 [0.82-1.17],0.8316317854081542
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20500,249,0.97 [0.80-1.18],0.7472709174545137
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20490,239,0.97 [0.79-1.18],0.7249824944837924
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18331,77,1.08 [0.79-1.47],0.642762407871954
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23751,62,1.03 [0.72-1.49],0.8605197815905321
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20714,553,1.04 [0.92-1.17],0.5480844037027699
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22961,149,1.13 [0.91-1.39],0.2696659335354529
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22616,2455,1.00 [0.94-1.06],0.8792888027861435
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20299,138,0.95 [0.73-1.23],0.6983222540767722
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20731,480,0.88 [0.76-1.02],0.1000291530638907
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22236,226,1.13 [0.95-1.35],0.1669221734351866
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20467,216,0.84 [0.66-1.05],0.1282018067688596
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21760,1509,0.96 [0.89-1.04],0.3270220861492783
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21275,1024,0.90 [0.81-1.00],0.047328723362747
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20215,54,0.80 [0.49-1.29],0.3518294376719552
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23025,213,1.10 [0.91-1.32],0.3262805231088294
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20332,171,0.90 [0.71-1.15],0.4186820169733728
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20277,116,0.94 [0.70-1.26],0.6741542004907024
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16095,43,0.89 [0.54-1.47],0.6500035524341825
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22926,1036,1.07 [0.98-1.17],0.1167803182763723
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17773,87,1.00 [0.74-1.36],0.9966599377821128
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23166,98,1.02 [0.77-1.35],0.8959778239688148
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23632,198,0.97 [0.78-1.20],0.782884737005386
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23455,21,1.47 [1.00-2.17],0.0506707986357091
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23052,1162,1.00 [0.91-1.09],0.9789226421923564
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23624,56,1.18 [0.84-1.67],0.341605664681504
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23596,203,1.13 [0.94-1.37],0.1846884622105664
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20991,218,1.08 [0.89-1.30],0.4424393776989621
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Dialysis,21935,45,1.49 [1.13-1.95],0.0040033013783599
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23352,284,1.04 [0.89-1.23],0.6015864124034884
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17837,151,1.06 [0.85-1.32],0.6137175713292597
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18023,337,0.98 [0.84-1.15],0.8413320862148366
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18557,871,1.05 [0.95-1.15],0.3397419746845116
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18478,4305,1.01 [0.96-1.06],0.698347998401744
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23623,55,1.46 [1.14-1.87],0.002471766821071
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21774,181,1.11 [0.91-1.35],0.3143823691896157
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23293,347,1.27 [1.13-1.43],9.073531301926824e-05
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23362,108,1.04 [0.80-1.34],0.792092840646022
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17949,263,1.02 [0.86-1.21],0.8041516930436138
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20838,65,1.20 [0.88-1.63],0.2431164487994747
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19800,2114,1.02 [0.96-1.08],0.5661669411487651
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17804,118,1.05 [0.81-1.35],0.7247212990795713
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23761,57,0.91 [0.59-1.40],0.6775430953424022
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23761,70,1.30 [1.00-1.70],0.0525371151123648
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22697,1924,1.00 [0.94-1.07],0.9634740173734316
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21183,410,1.03 [0.89-1.19],0.7258092456966596
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23169,101,1.05 [0.80-1.39],0.7133112631058169
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23718,325,1.09 [0.94-1.27],0.2476587461919174
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23717,76,1.07 [0.78-1.47],0.6800692528803032
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22424,1651,1.02 [0.94-1.09],0.6811996472165901
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23126,180,1.29 [1.10-1.52],0.0016179569267794
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17818,132,0.87 [0.66-1.17],0.3587972309882735
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18020,334,0.89 [0.74-1.06],0.1867076598721245
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17789,103,1.25 [0.99-1.57],0.056551785058227
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17868,182,1.03 [0.83-1.27],0.795036989109052
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21818,225,1.14 [0.96-1.35],0.1440456253748066
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23500,107,0.95 [0.70-1.29],0.7616335964909446
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17946,260,1.05 [0.88-1.25],0.5702383322567137
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17777,91,0.51 [0.33-0.79],0.0026320840016307
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18235,549,1.02 [0.90-1.15],0.8047147472622709
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17823,137,1.03 [0.80-1.32],0.8419774566053415
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18192,506,1.03 [0.91-1.17],0.6264266612013598
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23602,34,0.74 [0.39-1.39],0.3484119076725593
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23620,2027,1.00 [0.94-1.07],0.9460300931881211
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21736,143,0.92 [0.71-1.20],0.5333254531633136
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21970,80,1.30 [1.02-1.67],0.0366329069237729
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23466,32,1.13 [0.72-1.78],0.5954555515624804
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20900,127,1.03 [0.80-1.33],0.8117658588293738
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23662,228,1.06 [0.88-1.27],0.5605286822013116
RGL2,Ral guanine nucleotide dissociation stimulator-like 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17805,119,0.90 [0.67-1.20],0.4616775928715797
